Amanote Research

Amanote Research

    RegisterSign In

Advances in the Treatment of Monoclonal Gammopaties: The Emerging Role of Targeted Therapy in Plasma Cell Dyscrasias

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s3088
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
Date

September 1, 2008

Authors
Domenico Russo
Publisher

Informa UK Limited


Related search

The Non-Coding RNA Landscape of Plasma Cell Dyscrasias

Cancers
Cancer ResearchOncology
2020English

Recent Advances in Targeted Therapy of Colorectal Cancer: Impacts of Monoclonal Antibodies Nanoconjugates

BioImpacts
BiochemistryMedicineGeneticsMolecular BiologyPharmaceutical Science
2019English

Plasma Cell Dyscrasias: A Current Perspective

Acta Haematologica
MedicineHematology
1982English

Emerging Therapy for the Treatment of Mantle Cell Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2014English

Role of Monoclonal Antibodies in the Treatment of Asthma

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

Advances in Targeted Therapy for Malignant Lymphoma

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2020English

Role of Cytokine Therapy for Renal Cell Carcinoma in the Era of Targeted Agents

Current Oncology
Oncology
2009English

Current Perspectives in Metastatic Renal Cell Carcinoma Treatment: The Role of Targeted Therapies

2013English

Advances in the Treatment of Hairy Cell Leukemia

Journal of Hematology & Thromboembolic Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy